CoChat

Integrated Brain Atlas for Unbiased Mapping of Nervous System Effects Following Liraglutide Treatment

Open access

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Abstract

Light Sheet Fluorescence Microscopy (LSFM) of whole organs, in particular the brain, offers a plethora of biological data imaged in 3D. This technique is however often hindered by cumbersome non-automated analysis methods. Here we describe an approach to fully automate the analysis by integrating with data from the Allen Institute of Brain Science (AIBS), to provide precise assessment of the distribution and action of peptide-based pharmaceuticals in the brain. To illustrate this approach, we examined the acute central nervous system effects of the glucagon-like peptide-1 (GLP-1) receptor agonist liraglutide. Peripherally administered liraglutide accessed the hypothalamus and brainstem, and led to activation in several brain regions of which most were intersected by projections from neurons in the lateral parabrachial nucleus. Collectively, we provide a rapid and unbiased analytical framework for LSFM data which enables quantification and exploration based on data from AIBS to support basic and translational discovery.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-018-28496-6

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Multi-modality brain atlas integrating information from user data and AIBS data portal. (a) LSFM data showing brain distribution of labelled peptides (pink), as well as brain activation patterns (blue) using whole brain IHC staining for c-Fos. Top left drawing shows a mouse brain (yellow) imaged by a light sheet (green). Image credit: LaVision BioTec. (b) Histology data showing receptor location based on in situ hybridization (ISH). (c) Connectivity maps from AIBS3. Left: example of injected viral tracer. Right: Colored circles indicating the primary injection site of each experiment. © 2011 Allen Institute for Brain Science. Allen Mouse Brain Connectivity atlas. Available from: connectivity.brain-map.org. (d) Screen shots from a commercial 3D image rendering software used to explore overlay images of data mapped to the integrated brain atlas. (e) Illustration showing that all mapped data can be quantified automatically using the annotation of the CCFv33. The graph data is from Fig. 2b. (f) Illustration of the integrated brain atlas allowing quantification and comparison between experiments from different image modalities and labelling techniques. Data can be easily navigated as maximum intensity projections (3D) or orthogonal projections (2D).
Figure 1 Multi-modality brain atlas integrating information from user data and AIBS data portal. (a) LSFM data showing brain distribution of labelled peptides (pink), as well as brain activation patterns (blue) using whole brain IHC staining for c-Fos. Top left drawing shows a mouse brain (yellow) imaged by a light sheet (green). Image credit: LaVision BioTec. (b) Histology data showing receptor location based on in situ hybridization (ISH). (c) Connectivity maps from AIBS3. Left: example of injected viral tracer. Right: Colored circles indicating the primary injection site of each experiment. © 2011 Allen Institute for Brain Science. Allen Mouse Brain Connectivity atlas. Available from: connectivity.brain-map.org. (d) Screen shots from a commercial 3D image rendering software used to explore overlay images of data mapped to the integrated brain atlas. (e) Illustration showing that all mapped data can be quantified automatically using the annotation of the CCFv33. The graph data is from Fig. 2b. (f) Illustration of the integrated brain atlas allowing quantification and comparison between experiments from different image modalities and labelling techniques. Data can be easily navigated as maximum intensity projections (3D) or orthogonal projections (2D).CC BY · PubMed Central
Figure 2 Brain regions with liraglutideVT750 access. (a) Left: 2D coronal projections from data acquired with LSFM following liraglutideVT750 administration in C57BL/6J mice. The specific signal was mapped to the integrated brain atlas for quantification following auto-fluorescence background reduction by spectral unmixing. Right: 2D projection showing a mapped liraglutideVT750 signal overlaid onto the CCFv3 atlas template3. Automated quantification was achieved using the corresponding annotations. (b) Bar graph showing the mean fold change and standard deviation (SD) of the total fluorescence signal in selected brain regions comparing liraglutideVT750 and vehicle (n = 5). An asterisk marks significant difference between treatments when analyzed in individual brain regions using a false discovery rate value of 5% to correct for multiple comparisons. Note the split y-axis when interpreting results and standard deviations. See Supplementary Table 1 for full brain region names. (c) Maximum intensity projection of the average liraglutideVT750 signal computed from the individual brains in the study group (n = 5).
Figure 2 Brain regions with liraglutideVT750 access. (a) Left: 2D coronal projections from data acquired with LSFM following liraglutideVT750 administration in C57BL/6J mice. The specific signal was mapped to the integrated brain atlas for quantification following auto-fluorescence background reduction by spectral unmixing. Right: 2D projection showing a mapped liraglutideVT750 signal overlaid onto the CCFv3 atlas template3. Automated quantification was achieved using the corresponding annotations. (b) Bar graph showing the mean fold change and standard deviation (SD) of the total fluorescence signal in selected brain regions comparing liraglutideVT750 and vehicle (n = 5). An asterisk marks significant difference between treatments when analyzed in individual brain regions using a false discovery rate value of 5% to correct for multiple comparisons. Note the split y-axis when interpreting results and standard deviations. See Supplementary Table 1 for full brain region names. (c) Maximum intensity projection of the average liraglutideVT750 signal computed from the individual brains in the study group (n = 5).CC BY · PubMed Central
Figure 3 Distance map calculations. (a) Fenestrated capillaries visualized by maximum intensity projection of a MECA-32VT750 brain signal overlaid onto the CCFv3 template3. (b) Maximum intensity projection of average liraglutideVT750 signal (n = 5) overlaid onto the CCFv3 template3. (c) Coronal projection of the MECA-32VT750 signal registered to the atlas space and overlaid onto the CCFv3 template3. (d) Distance map constructed from the MECA-32VT750 signal. The value at a given voxel was assigned as the shortest Euclidian distance to a voxel classified as MECA-32VT750 positive. Blue indicate voxels close to fenestrated capillaries, while yellow indicate voxels far from fenestrated capillaries. (e) Average liraglutideVT750 signal overlaid onto a coronal section of the CCFv3 template3. (f) Center of mass distances computed for the liraglutideVT750 signals described in Fig. 2. The computation was performed in the brain regions marked for discovery in Fig. 2b.
Figure 3 Distance map calculations. (a) Fenestrated capillaries visualized by maximum intensity projection of a MECA-32VT750 brain signal overlaid onto the CCFv3 template3. (b) Maximum intensity projection of average liraglutideVT750 signal (n = 5) overlaid onto the CCFv3 template3. (c) Coronal projection of the MECA-32VT750 signal registered to the atlas space and overlaid onto the CCFv3 template3. (d) Distance map constructed from the MECA-32VT750 signal. The value at a given voxel was assigned as the shortest Euclidian distance to a voxel classified as MECA-32VT750 positive. Blue indicate voxels close to fenestrated capillaries, while yellow indicate voxels far from fenestrated capillaries. (e) Average liraglutideVT750 signal overlaid onto a coronal section of the CCFv3 template3. (f) Center of mass distances computed for the liraglutideVT750 signals described in Fig. 2. The computation was performed in the brain regions marked for discovery in Fig. 2b.CC BY · PubMed Central
Figure 4 Comparison of glp-1r localization and average liraglutideVT750 distribution. (a) Concept behind aligning a 2D histology ISH image (right) with 3D LSFM data (left). A histology image was aligned to an interpolated section of the integrated brain atlas template. Once aligned a similar interpolated projection from the average liraglutideVT750 distribution signal could be generated. Example ISH section with zoom panel at SO region. Red color indicates cells positive for glp-1r. (b) Heat map (blue) representation of ISH section from (a) aligned with the average liraglutideVT750 signal (pink) from Fig. 2c. The signals are overlaid onto separate halves of the CCFv3 template3.
Figure 4 Comparison of glp-1r localization and average liraglutideVT750 distribution. (a) Concept behind aligning a 2D histology ISH image (right) with 3D LSFM data (left). A histology image was aligned to an interpolated section of the integrated brain atlas template. Once aligned a similar interpolated projection from the average liraglutideVT750 distribution signal could be generated. Example ISH section with zoom panel at SO region. Red color indicates cells positive for glp-1r. (b) Heat map (blue) representation of ISH section from (a) aligned with the average liraglutideVT750 signal (pink) from Fig. 2c. The signals are overlaid onto separate halves of the CCFv3 template3.CC BY · PubMed Central
Figure 5 Neural activation following liraglutide administration. (a) Example images of c-Fos response in liraglutide vs vehicle dosed C57BL/6J mice. Bregma coordinates denote the anatomical location together with coronal atlas plates. Image credit: Allen Institute. (b) c-Fos heat map computed from one liraglutide injected mouse. See also Supplementary Fig. 8. (c) Bar graph showing the mean fold change and standard deviation (SD) of total c-Fos heat map signal in selected brain regions comparing liraglutide and vehicle dosed animals. Regions were selected as having either liraglutideVT750 access, GLP-1R expression, or c-Fos response. An asterisk marks significant difference between treatments when analyzed in individual brain regions using a false discovery rate value of 20% to correct for multiple comparisons. See Supplementary Table 1 for full brain region names. (d) Computed average c-Fos signal from liraglutide injected animals (left), and vehicle injected animals (right). (e) Liraglutide specific c-Fos increase overlaid with the average liraglutideVT750 distribution from Fig. 2c.
Figure 5 Neural activation following liraglutide administration. (a) Example images of c-Fos response in liraglutide vs vehicle dosed C57BL/6J mice. Bregma coordinates denote the anatomical location together with coronal atlas plates. Image credit: Allen Institute. (b) c-Fos heat map computed from one liraglutide injected mouse. See also Supplementary Fig. 8. (c) Bar graph showing the mean fold change and standard deviation (SD) of total c-Fos heat map signal in selected brain regions comparing liraglutide and vehicle dosed animals. Regions were selected as having either liraglutideVT750 access, GLP-1R expression, or c-Fos response. An asterisk marks significant difference between treatments when analyzed in individual brain regions using a false discovery rate value of 20% to correct for multiple comparisons. See Supplementary Table 1 for full brain region names. (d) Computed average c-Fos signal from liraglutide injected animals (left), and vehicle injected animals (right). (e) Liraglutide specific c-Fos increase overlaid with the average liraglutideVT750 distribution from Fig. 2c.CC BY · PubMed Central
Figure 6 Comparing brain connectivity maps with whole brain c-Fos data. (a) Top: Part of primary injection site (CEA) in a Prkcd-GluCla-CFP-IRES-Cre mouse. Bottom: Part of primary injection site (PB) in a slc17ac cre mouse. ©2011 Allen Institute for Brain Science. Allen Mouse Brain Connectivity atlas. Available from: connectivity.brain-map.org. (b) Connectivity maps visualized by horizontal maximum intensity projection overlaid with the average c-Fos increase following liraglutide administration from Fig. 5e. (c) Coronal projection images showing downloaded glutamatergic projections from PB, and PKD-delta+ projections from CEA, together with the average c-Fos increase following liraglutide administration. Signals are overlaid onto the CCFv3 template3.
Figure 6 Comparing brain connectivity maps with whole brain c-Fos data. (a) Top: Part of primary injection site (CEA) in a Prkcd-GluCla-CFP-IRES-Cre mouse. Bottom: Part of primary injection site (PB) in a slc17ac cre mouse. ©2011 Allen Institute for Brain Science. Allen Mouse Brain Connectivity atlas. Available from: connectivity.brain-map.org. (b) Connectivity maps visualized by horizontal maximum intensity projection overlaid with the average c-Fos increase following liraglutide administration from Fig. 5e. (c) Coronal projection images showing downloaded glutamatergic projections from PB, and PKD-delta+ projections from CEA, together with the average c-Fos increase following liraglutide administration. Signals are overlaid onto the CCFv3 template3.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 33 references

Cited by

See all 95

Metadata

Authors
Salinas, C. B. G., Lu, T. T.-H., Gabery, S., Marstal, K., Alanentalo, T., Mercer, A. J., Cornea, A., Conradsen, K., Hecksher-Sørensen, J., Dahl, A. B., Knudsen, L. B., & Secher, A.
Affiliations
  • Novo Nordisk (Denmark) (DK)
  • Erasmus MC (NL)
  • Novo Nordisk (United States) (US)
  • Technical University of Denmark (DK)
Corresponding author
Knudsen, Lotte Bjerre
Venue
Scientific Reports
Published
2018-07-09
Volume
8
Issue
1
Pages
10310-10310
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2809697129
Cited by
95
References
33
Citations by year
2026: 10 · 2025: 11 · 2024: 14 · 2023: 12 · 2022: 13 · 2021: 8 · 2020: 17 · 2019: 7 · 2018: 3
FWCI
4.57
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Lund University Publications (Lund University) (submittedVersion)
  • Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion, other-oa)
  • RePub (Erasmus University Rotterdam) (submittedVersion)
Funders
  • Innovationsfonden
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek (13351, 184.033.111)
  • Novo Nordisk
  • Stichting voor de Technische Wetenschappen (13351)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biophysics › Cell Image Analysis Techniques
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biophysics › Advanced Fluorescence Microscopy Techniques
Keywords
liraglutide, GLP-1 receptor agonists, light-sheet microscopy, automated image analysis, hypothalamus, brainstem, lateral parabrachial nucleus, central nervous system effects
MeSH terms
Glucagon-Like Peptide-1 Receptor, Liraglutide, Glucagon-Like Peptide-1 Receptor Agonists, Animals, Brain Mapping, Brain Stem, Eating, Hypoglycemic Agents, Hypothalamus, Mice, Inbred C57BL, Microscopy, Fluorescence, Nervous System, Proto-Oncogene Proteins c-fos, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Integrated Brain Atlas for Unbiased Mapping of Nervous System Effects Following Liraglutide Treatment. https://app.cochat.ai/papers/10.1038/s41598-018-28496-6
The paper
Salinas, C. B. G., Lu, T. T.-H., Gabery, S., Marstal, K., Alanentalo, T., Mercer, A. J., Cornea, A., Conradsen, K., Hecksher-Sørensen, J., Dahl, A. B., Knudsen, L. B., & Secher, A. (2018). Integrated Brain Atlas for Unbiased Mapping of Nervous System Effects Following Liraglutide Treatment. Scientific Reports. https://doi.org/10.1038/s41598-018-28496-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.